bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/780858

Studying the drug treatment pattern based on the action of drug and multi-layer network model

Yu, L.·Shi, Y.·Gao, L.·Zou, Q.
View original source ↗Export metadata ↓

Abstract

ObjectivesA drug can treat multiple diseases, indicating that the treatment of the drug has certain patterns. In this paper, we studied the treatment pattern of drugs from a new perspective based on the action of drug and multi-layer network model (STAM). Diseases affect the gene expression in related tissues and each disease corresponds to a tissue-specific protein-protein interaction (TSPPI) network. Therefore, a drug is associated with a multi-layer TSPPI network associated with diseases it treats. Single tissue-specific PPI network cannot consider all disease-related information, leading to find the potential treatment pattern of drugs difficultly. Research on multi-layer networks can effectively solve this disadvantage. Furthermore, proteins usually interact with other proteins in PPI to achieve specific functions, such as causing disease. Hence, studying the drug treatment patterns is equivalent to study common module structures in the multi-layer TSPPI network corresponding to drug-related diseases. Knowing the treatment patterns of the drug can help to understand the action mechanisms of the drug and to identify new indications of the drug.\n\nMethodsIn this paper, we were based on the action of drug and multi-layer network model to study the treatment patterns of drugs. We named our method as STAM. As a case of our proposed method STAM, we focused on a study to trichostatin A (TSA) and three diseases it treats: leukemia, breast cancer, and prostate cancer. Based on the therapeutic effects of TSA on various diseases, we constructed a tissue-specific protein-protein interaction (TSPPI) network and applied a multi-layer network module mining algorithm to obtain candidate drug-target modules. Then, using the genes affected by TSA and related to the three diseases, we employed Gene Ontology (GO), the modules significance, co-expression network and literatures to filter and analyze the identified drug-target modules. Finally, two modules (named as M17 and M18) were preserved as the potential treatment patterns of TSA.\n\nResultsThe processed results based on the above framework STAM demonstrated that M17 and M18 had strong potential to be the treatment patterns of TSA. Through the analysis of the significance, composition and functions of the selected drug-target modules, we validated the feasibility and rationality of our proposed method STAM for identifying the drug treatment pattern.\n\nConclusionThis paper studied the drug treatment pattern from a new perspective. The new method STAM used a multi-layer network model, which overcame the shortcomings of the single-layer network, and combined the action of drug. Research on drug treatment model provides new research ideas for disease treatment.

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Yu, L., Shi, Y., Gao, L., Zou, Q.. 2019-09-24. Studying the drug treatment pattern based on the action of drug and multi-layer network model. https://doi.org/10.1101/780858

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

scRM: A single-cell foundation model trained on scRNA-seq reads

To our knowledge, scRM is the first single-cell foundation model trained on sequencing reads, demonstrating that raw data pretraining is not only feasible but competitive at a fraction of the computational cost. We anticipate that scaling this framework and exploring alternative architectures will unlock biological information inaccessible to count models and extend the dataset-specific pretraining it already makes possible. The source code is available at https://github.com/altos-labs/scRM.

bioinformatics↗
bioRxiv2026

Local fractal dimension as an indicator of functional reorganization in molecular interaction networks

Changes in protein abundance incompletely describe how molecular perturbations reshape cellular organization. Here we introduce DIFFRACT, a framework that integrates quantitative proteomics with protein-protein interaction networks to identify reorganization through changes in local fractal dimension. Molecular associations define effective distances between connected proteins, allowing the geometry of their surrounding network neighborhoods to be compared across conditions. Analyses across four organisms (E. coli, A. thaliana, C. elegans, and H. sapiens) and three interaction resources (STRING, BioGRID, and IntAct) establish heterogeneous local scaling, while controlled perturbations demonstrate sensitivity to regional changes and invariance to uniform distance rescaling. Applied to RAVER1-deficient A549 cells, DIFFRACT identifies components associated with established RNA-regulatory functions and candidate roles in tRNA biology, mitochondrial organization and ciliogenesis. Selected RNA-regulatory and ciliary themes are not significantly enriched by abundance-ranked gene set analysis, supporting complementary information from network geometry. Selected functional annotations also recur in HEK293T cells. Guided by the ciliary predictions, we show that RAVER1 depletion increases the proportion of ciliated A549 cells 2.57-fold and increases cilium length. DIFFRACT thus connects changes in molecular network geometry to experimentally testable biological responses, extending the interpretation of proteomic perturbations beyond differential abundance.

bioinformatics↗
bioRxiv2026

Peripheral Exercise Transcriptomes Do Not Converge on Glutamatergic or Neuroinflammatory Signatures: A Cross-Platform Meta-Analysis

Executive dysfunction following physical overtraining has been linked to glutamatergic dysregulation in the lateral prefrontal cortex (LPFC), but whether this central mechanism is reflected in peripheral gene expression is unknown. This study tested whether peripheral transcriptomic responses to exercise converge on the glutamatergic or neuroinflammatory pathways implicated in LPFC dysfunction. Three publicly available GEO datasets spanning skeletal muscle, whole blood, and circulating neutrophils were analyzed across four exercise groups using limma, with a discovery threshold of nominal p < 0.05 and absolute log2 fold change above 0.5. Differential expression analysis identified 7,311 unique differentially expressed genes (DEGs) across the four contrasts, but overlap between datasets was limited: 7 genes were shared between skeletal muscle and blood, 38 between skeletal muscle and the GSE43856 contrasts, and 90 between blood and the GSE43856 contrasts, with none significant across all three studies. Gene Ontology and KEGG enrichment of the DEG union identified ribonucleoprotein complex biogenesis, ribosome biogenesis, protein folding, and T cell activation as the dominant biological processes; no glutamatergic or neuroinflammatory terms reached significance. Cross-tissue concordance between skeletal muscle and blood was absent (r = 0). Effect sizes among the genes driving the top enriched pathways were dominated by ribosomal proteins, heat shock proteins, and translation initiation factors rather than glutamate receptors or transporters. These findings indicate that peripheral transcriptomic responses to exercise are tissue-specific and dominated by proteostasis, translational, and immune programs rather than glutamatergic signaling. Direct assessment of central nervous system tissue or fluid-based glutamatergic biomarkers may be required to link overtraining-induced fatigue to LPFC dysfunction.

bioinformatics↗